Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
Revagenix's investors include Novo Holdings, Repair Impact Fund, Tenmile.
Revagenix is headquartered in San Mateo, United States.
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
Revagenix is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Revagenix — Funding & Investors." VCBacked, January 5, 2024, https://www.vcbacked.co/company/revagenix. Accessed July 28, 2026.
VCBacked. (2024). Revagenix — Funding & Investors. Retrieved July 28, 2026, from https://www.vcbacked.co/company/revagenix
{{cite web |title=Revagenix — Funding & Investors |url=https://www.vcbacked.co/company/revagenix |website=VCBacked |access-date=July 28, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated